Benefits derived from this development are therefore apparent for sponsor countries of medical research, but benefits for the developing countries, or host countries of the research, for example in the form of access to treatment and strengthening of the health care system, can also be great.
Hagsmunir rannsóknaraðila eru því augljósir, en þetta getur líka þjónað hagsmunum þróunarríkjanna, m.a. í formi aðgengis að lyfjum og sterkara heilbrigðiskerfis.